[Tuberculous otitis media. Report of 3 cases].
Tuberculous otitis media (TOM) is a rare cause of chronic suppurative infection of the middle ear. Due to that the symptoms and signs are often indistinguishable from those of nontuberculosis chronic otitis media and the fact that the index of suspicion is low, there is frequently a considerable delay prior to diagnosis. This can lead to irreversible complications such as facial nerve paralysis and labyrinthitis. Medical therapy with antituberculous drugs is usually effective. We report three cases with TOM diagnosticated and followed up in our Service from january 1993 to july 2001. Their charts were retrospectively reviewed for relevant historical data, physical findings, complementary studies, treatment and clinical response. We performed a review of the literature, emphasizing that TOM should be considered in the differential diagnosis of chronic otitis media.
Benito González
J J
JJ
Servicio ORL y Patología Cérvico-Facial, Hospital Clinico Universitario de Salamanca.
Benito González
F
F
Santa Cruz Ruiz
S
S
Gómez González
J L
JL
Coscarón Blanco
E
E
Cordero Sánchez
M
M
del Cañizo Alvarez
A
A
D000328:Adult; D000368:Aged; D000658:Amoxicillin / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use; D002558:Cerebrospinal Fluid Otorrhea / Q000134:cerebrospinal fluid / Q000382:microbiology; D004338:Drug Combinations; D004427:Ear Diseases / Q000134:cerebrospinal fluid / Q000188:drug therapy / Q000382:microbiology; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D009164:Mycobacterium Infections / Q000188:drug therapy / Q000382:microbiology; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification; D010033:Otitis Media / Q000134:cerebrospinal fluid* / Q000188:drug therapy / Q000382:microbiology; D010406:Penicillins / Q000627:therapeutic use; D011512:Proteus Infections / Q000188:drug therapy / Q000382:microbiology; D011513:Proteus mirabilis / Q000302:isolation & purification; D011718:Pyrazinamide / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000382:microbiology; D013211:Staphylococcus aureus / Q000302:isolation & purification; D014376:Tuberculosis / Q000134:cerebrospinal fluid* / Q000188:drug therapy / Q000382:microbiology
D000995:Antitubercular Agents; D004338:Drug Combinations; D010406:Penicillins; C087181:isoniazid, pyrazinamide, rifampin drug combination; D011718:Pyrazinamide; D000658:Amoxicillin; D007538:Isoniazid; D012293:Rifampin